1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

Summary

GlobalData’s new report, "Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020", provides key market data on the Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Uterine Fibroid Embolization (UFE) Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific 5
3.1 Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, 2005-2020 5
3.2 Uterine Fibroid Embolization (UFE) Procedures, Asia Pacific, Category Comparison by Procedures, 2005-2020 6
3.3 Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, 2005-2013 7
3.4 Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, 2013-2020 9
4 Uterine Fibroid Embolization (UFE) Procedures, Australia 11
4.1 Uterine Fibroid Embolization (UFE) Procedures, Australia, 2005-2013 11
4.2 Uterine Fibroid Embolization (UFE) Procedures, Australia, 2013-2020 13
5 Uterine Fibroid Embolization (UFE) Procedures, China 15
5.1 Uterine Fibroid Embolization (UFE) Procedures, China, 2005-2013 15
5.2 Uterine Fibroid Embolization (UFE) Procedures, China, 2013-2020 17
6 Uterine Fibroid Embolization (UFE) Procedures, India 19
6.1 Uterine Fibroid Embolization (UFE) Procedures, India, 2005-2013 19
6.2 Uterine Fibroid Embolization (UFE) Procedures, India, 2013-2020 21
7 Uterine Fibroid Embolization (UFE) Procedures, Japan 23
7.1 Uterine Fibroid Embolization (UFE) Procedures, Japan, 2005-2013 23
7.2 Uterine Fibroid Embolization (UFE) Procedures, Japan, 2013-2020 24
8 Uterine Fibroid Embolization (UFE) Procedures, South Korea 26
8.1 Uterine Fibroid Embolization (UFE) Procedures, South Korea, 2005-2013 26
8.2 Uterine Fibroid Embolization (UFE) Procedures, South Korea, 2013-2020 28
9 Appendix 30
9.1 Research Methodology 31
9.1.1 Coverage 31
9.1.2 Secondary Research 31
9.1.3 Primary Research 32
9.1.4 Market Modeling and Forecasting 33
9.1.5 Company Share Analysis 36
9.1.6 Distribution Share Analysis 37
9.2 Expert Panel 37
9.3 GlobalData Consulting 38
9.4 Contact Us 38
9.5 Disclaimer 38

1.1 List of Tables
Table 1: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, 2005-2020 5
Table 2: Uterine Fibroid Embolization (UFE) Procedures, Asia Pacific, Category Comparison by Procedures, 2005-2020 6
Table 3: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, Historic, 2005-2013 8
Table 4: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, Forecast, 2013-2020 10
Table 5: Uterine Fibroid Embolization (UFE) Procedures, Australia, Historic, 2005-2013 12
Table 6: Uterine Fibroid Embolization (UFE) Procedures, Australia, Forecast, 2013-2020 14
Table 7: Uterine Fibroid Embolization (UFE) Procedures, China, Historic, 2005-2013 16
Table 8: Uterine Fibroid Embolization (UFE) Procedures, China, Forecast, 2013-2020 18
Table 9: Uterine Fibroid Embolization (UFE) Procedures, India, Historic, 2005-2013 20
Table 10: Uterine Fibroid Embolization (UFE) Procedures, India, Forecast, 2013-2020 22
Table 11: Uterine Fibroid Embolization (UFE) Procedures, Japan, Historic, 2005-2013 23
Table 12: Uterine Fibroid Embolization (UFE) Procedures, Japan, Forecast, 2013-2020 25
Table 13: Uterine Fibroid Embolization (UFE) Procedures, South Korea, Historic, 2005-2013 27
Table 14: Uterine Fibroid Embolization (UFE) Procedures, South Korea, Forecast, 2013-2020 29
Table 15: Total Number of Primary Research Participants, General Surgery Market, by Country 33

1.2 List of Figures
Figure 1: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, 2005-2020 5
Figure 2: Uterine Fibroid Embolization (UFE) Procedures, Asia Pacific, Category Comparison by Procedures, 2005-2020 6
Figure 3: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, Historic, 2005-2013 7
Figure 4: Uterine Fibroid Embolization (UFE) Procedures, Asia-Pacific, Forecast, 2013-2020 9
Figure 5: Uterine Fibroid Embolization (UFE) Procedures, Australia, Historic, 2005-2013 11
Figure 6: Uterine Fibroid Embolization (UFE) Procedures, Australia, Forecast, 2013-2020 13
Figure 7: Uterine Fibroid Embolization (UFE) Procedures, China, Historic, 2005-2013 15
Figure 8: Uterine Fibroid Embolization (UFE) Procedures, China, Forecast, 2013-2020 17
Figure 9: Uterine Fibroid Embolization (UFE) Procedures, India, Historic, 2005-2013 19
Figure 10: Uterine Fibroid Embolization (UFE) Procedures, India, Forecast, 2013-2020 21
Figure 11: Uterine Fibroid Embolization (UFE) Procedures, Japan, Historic, 2005-2013 23
Figure 12: Uterine Fibroid Embolization (UFE) Procedures, Japan, Forecast, 2013-2020 24
Figure 13: Uterine Fibroid Embolization (UFE) Procedures, South Korea, Historic, 2005-2013 26
Figure 14: Uterine Fibroid Embolization (UFE) Procedures, South Korea, Forecast, 2013-2020 28
Figure 15: GlobalData Epidemiology-Based Forecasting Model 35
Figure 16: GlobalData Capital Equipment-Based Forecasting Model 36
Figure 17: Primary Interviews by Participant Type (%) 37

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.